Literature DB >> 7703368

Formation and stability of pyrrole adducts in the reaction of levuglandin E2 with proteins.

E DiFranco1, G Subbanagounder, S Kim, K Murthi, S Taneda, V M Monnier, R G Salomon.   

Abstract

Levuglandin (LG) E2 is rapidly sequestered by covalent binding with proteins. The reaction of LGE2 with a protein in neutral aqueous solution exhibits two phases. A metastable adduct rapidly accumulates initially. In the second phase, a protein-bound pyrrole is generated. Pyrrole formation and stability were monitored with an immunoassay using antibodies that were raised against a stable isostere. That LG-derived pyrroles are the major products (> 76%) of the LGE2-protein reaction is suggested by the level of antibody binding found for LG-protein adducts compared with that found for a pyrrole derived from LGE2 and 6-amino-1-hexanol. Because the initial metastable LG-protein adduct is a reactive electrophile, it can be trapped with amines, such as glycine, to give stable ternary adducts that do not cross-react with the antibodies. Although highly alkylated pyrroles are chemically sensitive compounds, the protein-bound LG-derived pyrrole appears to be stable in aqueous solution at pH 7.4. Thus, it shows no decrease in immunoreactivity over several weeks. This discovery leads to the expectation that such pyrroles will accumulate in vivo, especially in proteins that do not turn over rapidly. Thus, the LG-derived protein-bound pyrrole may be a useful marker of oxidative lipid damage, and an immunoassay for this post-translational protein modification can be exploited as a mild, sensitive method for detecting and quantifying the generation of LGs in chronic inflammatory states.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7703368     DOI: 10.1021/tx00043a008

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  13 in total

1.  Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1.

Authors:  Casey Charvet; Wei-Li Liao; Gun-Young Heo; James Laird; Robert G Salomon; Illarion V Turko; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

Review 2.  Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

Authors:  P J Cimino; C Dirk Keene; Richard M Breyer; Kathleen S Montine; Thomas J Montine
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

3.  A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines.

Authors:  Lilu Guo; Venkataraman Amarnath; Sean S Davies
Journal:  Anal Biochem       Date:  2010-06-19       Impact factor: 3.365

4.  Molecular Structures of Isolevuglandin-Protein Cross-Links.

Authors:  Wenzhao Bi; Geeng-Fu Jang; Lei Zhang; John W Crabb; James Laird; Mikhail Linetsky; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-09-21       Impact factor: 3.739

Review 5.  Fatty acid oxidation in the pathogenesis of Alzheimer's disease.

Authors:  Thomas J Montine; Jason D Morrow
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

6.  Mass spectrometry detection of isolevuglandin adduction to specific protein residues.

Authors:  Casey D Charvet; Irina A Pikuleva
Journal:  Methods Mol Biol       Date:  2015

7.  Isoketals form cytotoxic phosphatidylethanolamine adducts in cells.

Authors:  C Blake Sullivan; Elena Matafonova; L Jackson Roberts; Venkataraman Amarnath; Sean S Davies
Journal:  J Lipid Res       Date:  2009-11-25       Impact factor: 5.922

8.  Methods for imaging and detecting modification of proteins by reactive lipid species.

Authors:  Ashlee N Higdon; Brian P Dranka; Bradford G Hill; Joo-Yeun Oh; Michelle S Johnson; Aimee Landar; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2009-05-14       Impact factor: 7.376

9.  Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.

Authors:  Casey D Charvet; James Laird; Yunfeng Xu; Robert G Salomon; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

10.  Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.

Authors:  Sean S Davies; Linda S Zhang
Journal:  Curr Pharmacol Rep       Date:  2017-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.